861613-82-3

Basic information

• Product Name: N-(2-iodo-4-iodophenyl)acetamide
• Synonyms: N-(2-iodo-4-iodophenyl)acetamide
• CAS NO: 861613-82-3
• Molecular Weight: 386.959
• Mol File: 861613-82-3.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: N-(2-iodo-4-iodophenyl)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(2-iodo-4-iodophenyl)acetamide(861613-82-3)
• EPA Substance Registry System: N-(2-iodo-4-iodophenyl)acetamide(861613-82-3)

Safety Data

• Hazardous Substances Data: 861613-82-3(Hazardous Substances Data)

Upstream product

• 533-70-0 2,4-diiodoaniline 
• 108-24-7 acetic anhydride 
• 622-50-4 4-Acetamido-1-iodobenzene 
• 64-19-7 acetic acid 
• 7697-37-2 nitric acid 
• 75-36-5 acetyl chloride 
• 62-53-3 aniline 
• 540-37-4 p-aminoiodobenzene 
• 103-84-4 Acetanilid 

Downstream Products

• 68867-20-9 6-iodo-2-methyl-1,3-benzothiazole 

Relevant articles and documents

Regioselective monobromination of aromatics via a halogen bond acceptor-donor interaction of catalytic thioamide and N-bromosuccinimide

Regioselective monobromination of various aromatics was achieved at room temperature using N-bromosuccinimide and 5 mol% of thioamides in acetonitrile. With thiourea as catalyst, activated aromatics, such as anisole, acetanilide, benzamide and phenol analogues containing electron donating or withdrawing groups, were brominated with high regioselectivity. Room temperature brominations of weakly activated aromatics and deactivated 9-fluorenone were accomplished by 5 mol% thioacetamide, higher substrates concentrations and longer reaction times. A backbonding of the bromine lone pairs with the π*of C[dbnd]S group and a halogen bond between the halogen bond donor bromine and the halogen bond acceptor sulfur of the thioamide are thought to be the principal interactions and cause of N-bromosuccinimide activation.

RADIOACTIVE IODINE LABELED STYRYL SUBSTITUTED AROMATIC HETEROCYCLIC COMPOUND

PROBLEM TO BE SOLVED: To provide a novel tau protein imaging agent that allows imaging of biological tau protein by a noninvasive, nuclear medical method. SOLUTION: The present invention provides a radioactive iodine labeled styryl substituted aromatic heterocyclic compound represented by a predetermined general formula or a salt thereof, or a radioactive medicine comprising the same. SELECTED DRAWING: None COPYRIGHT: (C)2016,JPOandINPIT

Radioactive iodine labeled compound, and, radioactive pharmaceutical containing the same (by machine translation)

PROBLEM TO BE SOLVED: and compatibility and affinity for both amyloidosis acryloyldimethyltauric, labeled compd. radioactive iodine. SOLUTION: the present invention, N, N-labeled compd. dimethyl benzene amine including radioactive iodine or its salt. Selected drawing: no (by machine translation)